The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
about
Lymph node tuberculosis mimicking malignancy on 18F-FDG PET/CT in two patients: A case report.18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and bDiagnosis and evaluation of gastric cancer by positron emission tomographyPositron emission tomography/computed tomography for bone tumors (Review).Primary pulmonary amyloidosis misdiagnosed as malignancy on dual-time-point fluoro-deoxyglucose positron emission tomography/computed tomography: A case report and review of the literature.Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a proDual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?Use of benzodiazepines before (18)F-FDG-PET/CT dual-phase imaging does not decrease the efficacy of the study.Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?Imaging of solitary pulmonary nodule-a clinical reviewPositron emission tomography findings in clinical mimics of lymphoma.When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.Dual-time-point positron emission tomography findings of benign mediastinal fluorine-18-fluorodeoxyglucose uptake in tuberculosis-endemic region.Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?Kikuchi-Fujimoto Disease with 18F-Fludeoxyglucose Uptake in Cervical Lymph Nodes on Dual-time-point Imaging Positron Emission Tomography/Computed Tomography Mimicking Malignant Disease.Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis.Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.Advanced kinetic modelling strategies: towards adoption in clinical PET imagingEfficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer
P2860
Q33744380-FE59F0D3-7A2E-4B38-9BBC-37F727573366Q33823389-603A63FE-F741-4C9C-A5BF-44F6684A1159Q34661633-1970A35E-408C-4A47-B91A-C55B96B4A50FQ34993781-51417EAC-5013-4B89-A4D4-C010396CCADFQ34993919-3590E716-18E0-4390-BF61-BC50C6A8AC20Q35104354-E7D9B0B5-66A2-4BAC-8180-333B9653C673Q36084996-D190EFFD-2CB8-4A87-B2C5-FFE5B4131996Q36771789-AE4B8E6F-E800-4BA8-A902-DD82ED3F0053Q36996436-678BA7CE-3C63-47EB-8842-6B3A7022CFD2Q37441366-E6EE25AB-A576-4D17-9ED1-D545CC80B580Q37896130-B32BF4E7-3350-488B-99CF-AD79F5347B29Q38077707-2C30282D-9DD3-4B92-88D1-2C20AF67FD28Q38253400-5BAA5114-B274-47EF-B5AC-0225FECB07C7Q38568419-F7C122A0-BDAB-4BF7-82AA-BAE601C1DCD6Q38673721-CBBD9904-9BD8-4596-AD05-C031CBB28B5AQ40202579-21A75D3B-1722-4144-B086-6FE6F63AC412Q41787672-7F896CCC-E9FE-41D6-A8A6-C073786103A3Q42733586-A12807A7-F25E-45C1-8160-A8AB4761E7ACQ51824709-E0547B96-92C3-48C3-9269-69C0A8EB0CBBQ52982946-D658EB8E-5EBE-409E-8DFA-C186034E943CQ53063558-42E713DA-C3CC-484A-A1A6-A27D513CBBD3Q53090206-0A6A2307-99C5-4304-9D95-260872DFA8F5Q53187493-F0591119-A81C-46DC-8DB2-4C0732E75F53Q53214090-0CB5DDB5-90EA-4223-9432-7C0E01809C49Q56835422-E1A3FF79-033E-46E7-9089-0811E5B59F80Q58802132-DA447BCB-5DE1-4C70-843C-26D333B1391A
P2860
The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The value of dual time point ( ...... malignant and benign lesions.
@en
The value of dual time point
@nl
type
label
The value of dual time point ( ...... malignant and benign lesions.
@en
The value of dual time point
@nl
prefLabel
The value of dual time point ( ...... malignant and benign lesions.
@en
The value of dual time point
@nl
P2093
P1433
P1476
The value of dual time point ( ...... malignant and benign lesions.
@en
P2093
P304
P356
10.1016/J.CRAD.2008.01.003
P577
2008-03-19T00:00:00Z